Cardiovascular Innovations and Applications (May 2023)

Possible Mechanisms of SARS-CoV2-Mediated Myocardial Injury

  • Bing Yu,
  • Yalin Wu,
  • Xiaosu Song,
  • Gaizhen Liu,
  • Fengqin Wang,
  • Fenfang Zhang,
  • Bin Liang

DOI
https://doi.org/10.15212/CVIA.2023.0031
Journal volume & issue
Vol. 8, no. 1
p. 981

Abstract

Read online

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly become a global health emergency. In addition to causing respiratory effects, SARS-CoV-2 can result in cardiac involvement leading to myocardial damage, which is increasingly being explored in the literature. Myocardial injury is an important pathogenic feature of COVID-19. The angiotensin-converting enzyme-2 receptor plays a key role in the pathogenesis of the virus, serving as a “bridge” allowing SARS-CoV-2 to invade the body. However, the exact mechanism underlying how SARS-CoV-2 causes myocardial injury remains unclear. This review summarizes the main possible mechanisms of myocardial injury in patients with COVID-19, including direct myocardial cell injury, microvascular dysfunction, cytokine responses and systemic inflammation, hypoxemia, stress responses, and drug-induced myocardial injury. Understanding of the underlying mechanisms would aid in proper identification and treatment of myocardial injury in patients with COVID-19.